中國藥典第一部英文版   [更多]

求購左氧氟沙星EP9.8版 需要是PDF可以復(fù)制版 多謝   [更多]

本人畢業(yè)論文要用到一些數(shù)據(jù)，需要一份截止目前為止的國內(nèi)藥品申請專利的數(shù)量和類型匯總（可專利點(diǎn)），然后這些申請成功的藥品之中已經(jīng)成功上市的專利數(shù)量匯總（成功轉(zhuǎn)化成商品，應(yīng)用到藥企的專利），就是簡單做個數(shù)據(jù)分析，分析我國的藥品專利商品化率，最好是有一些數(shù)據(jù)，如果有表格要做成三線表格，如果可以要和同期的國外藥品轉(zhuǎn)化率作對比，然后數(shù)據(jù)需要標(biāo)注一下數(shù)據(jù)的來源，有參考文獻(xiàn)要備注參考文獻(xiàn)，要盡快完成，謝謝~   [更多]

薄膜包衣預(yù)混劑信息   [更多]

求一份硫酸羥氯喹片的美國生產(chǎn)廠商，醫(yī)院和零售價格，和藥品的適應(yīng)癥   [更多]

重點(diǎn)查一下有沒有3mg/6mg劑型   [更多]

求購“Saccharin Sodium” BP2017 和BP2018的藥典標(biāo)準(zhǔn)各一份   [更多]

標(biāo)題：求購藥品信息 詳細(xì)要求： 需求名稱：求購藥品信息 具體要求：求購全文 要求時間：近期需要 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會每天過來看的，謝謝各位藥智的戰(zhàn)友們，價格可以商量   [更多]

本團(tuán)隊在進(jìn)行藥理研究中發(fā)現(xiàn)瑞戈非尼與帕唑帕尼存在治療肺纖維化的潛力，且動物實(shí)驗藥效十分顯著，現(xiàn)二者針對肺纖維化適應(yīng)癥的專利申請已獲國家知識產(chǎn)權(quán)局受理。本團(tuán)隊向意向進(jìn)行瑞戈非尼、帕唑帕尼仿制生產(chǎn)的公司尋求合作，開發(fā)該藥物治療肺纖維化的新適應(yīng)癥，將技術(shù)轉(zhuǎn)化為產(chǎn)品，進(jìn)行新藥注冊并上市。 若有開發(fā)該藥物新適應(yīng)癥的意愿，可聯(lián)系我們。   [更多]

1.Nihon Yakurigaku Zasshi. 2013 Jul;142(1):39-46. doi: 10.1254/fpj.142.39. Pharmacological and clinical properties of AIMIX combination tablets LD&HD, fixed-dose combination of irbesartan and amlodipine besilate. 2.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 3.Clin Ther. 2012 Aug;34(8):1705-19. doi: 10.1016/j.clinthera.2012.06.026. Epub 2012 Jul 30. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 4.Clin Ther. 2012 Aug;34(8):1720-34.e3. doi: 10.1016/j.clinthera.2012.07.001. Epub 2012 Jul 30. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 5.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 6J Cardiol. 2019 Mar 20. pii: S0914-5087(19)30053-X. doi: 10.1016/j.jjcc.2019.03.001. [Epub ahead of print] Arginine vasopressin antagonism in heart failure: Current status and possible new directions. Goldsmith SR1. 7.Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability 8.Expert Rev Neurother. 2017 Jan;17(1):59-75. Epub 2016 Oct 20. Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology. Tramutola A1, Arena A1,   [更多]